Jhunjhunwala & Co backed Star Health rises 3% after premium increases 12%
As per Trendlyne data, the highest target for stock goes up to Rs 920, while the average estimate of Rs 767 shows an upside of the potential of around 25% from the current market prices. Out of the 14 analysts covering the stock, seven of them have strong buy and buy ratings, while only six have strong sell and sell ratings and the other one has a hold rating.
